|
1. FDA reverses course; agrees to review Moderna flu vaccine Full story
2. Another win for GLP-1s and cancer risk: 5 study notes Full story
3. 2026 strategy check: Are your assumptions about care delivery still holding up? Get answers here.
4. FDA approves biosimilar for chemo-related infection risk Full story
5. Huntsman Cancer Institute to manufacture imaging drug, 1st in US Full story
6. Price isn't everything anymore — See how systems are redefining purchasing value, here.
7. 3 trends shaping the GLP-1 landscape Full story
8. Pennsylvania hospital to close, transition to outpatient care Full story
Becker's Learning Opportunities
9. Normalizing cost conversations is no longer optional. Learn why (and what to do about it) here.
10. Needlestick injuries fell 62% when hospitals combined training and safety devices. Learn how here.
11. Sharp HealthCare's new neuroscience program met its financial targets from the start. Learn how here.
12. Interested in more? See Becker’s full lineup of
webinars
and
whitepapers.
Apply to attend complimentary as a guest reviewer here! Opportunity exclusive to those directly employed by a provider organization.
|
.png)
